79 results
Balloon- versus self-expanding valve systems for treating small failed surgical aortic bioprostheses: the LYTEN trial
23 May 2022
Luigi provides us with the interventional cardiologist's point of view!
Currently, TAVR selection process is performed by matching the internal diameter of the surgically implanted bioprostheses to the external diameter of commercially available TAVR devices. Nonetheless, the impact of intrinsic design differences, such as supra vs intra-annular design,...
Reviewer
EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease
22 May 2022
Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!
Author
Transcaval versus transaxillary TAVR in contemporary practice - a propensity-weighted analysis
09 May 2022
As there has been no systematic comparison of transcaval and transaxillary access so far, the present study aimed to compare these two approaches with each other, as well as with transfemoral access.
Reviewer
Reviewer
Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair
10 Feb 2022
The authors hypothesized that disordered right ventricular to pulmonary artery (RV-PA) coupling may denote RV decompensation in patients undergoing transcatheter tricuspid valve repair (TTVR) that may correlate with poor clinical outcomes.
Reviewer
Reviewer
Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair
27 Jan 2022
As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.
Reviewer
Reviewer
Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR
26 Jan 2022
Recently, coronary access has been recognized as an important consideration in the lifetime management of patients with severe aortic stenosis...
Reviewer
30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results
21 Jan 2022
The study by Zahr et al. reports the results of an interim analysis assessing procedural and clinical outcomes at 30-day in 15 patients treated with the newly developed Medtronic Intrepid 35-F trans-femoral transcatheter mitral valve replacement (TMVR) system.
Reviewer
Iatrogenic atrial septal defects following transcatheter mitral valve repair and implications of interventional closures
21 Dec 2021
The authors investigated whether iatrogenic atrial septal defect closure post-transcatheter mitral valve edge-to-edge repair is superior to conservative therapy, and whether outcomes (death/heart failure hospitalization) differ between patients with and without an iASD post-TMVR.
Reviewer
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
19 Oct 2021
In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.
Reviewer
Reviewer
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis
24 Sep 2021
Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...
Reviewer
Reviewer
